Jan. 27, 2022, 2:11 a.m. | Matthew Ragoza, Tomohide Masuda, David Ryan Koes

cs.LG updates on arXiv.org arxiv.org

The goal of structure-based drug discovery is to find small molecules that
bind to a given target protein. Deep learning has been used to generate
drug-like molecules with certain cheminformatic properties, but has not yet
been applied to generating 3D molecules predicted to bind to proteins by
sampling the conditional distribution of protein-ligand binding interactions.
In this work, we describe for the first time a deep learning system for
generating 3D molecular structures conditioned on a receptor binding site. We …

3d arxiv bio

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Machine Learning Engineer (m/f/d)

@ StepStone Group | Düsseldorf, Germany

2024 GDIA AI/ML Scientist - Supplemental

@ Ford Motor Company | United States